Voriconazole;2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl)butan-2-ol;(aR,bS)-a-(2,4-Difluorophenyl)-5-fluoro-b-methyl-a-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol;UK-10949;(2R,3S)-2-(2,4-DIFLUOROPHENYL)-3-(5-FLUOROPYRIMIDIN-4-YL)-1-(1H-1,2,4-TRIAZOL-1-YL)BUTAN-2-OL;(aR,S)-a-(2,4-Difluorophenyl)-5-fluoro--methyl-a-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol;UK-109496;(2R,3S)-2-(2,4-Difluorophenyl)-3;(2R,3S)-2-(2,4-Difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-((1H)-1,2,4-triazol-1-yl)-butan-2-ol;Voriconazole solution;(2R,3S)-2-(2,4-Difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol;2S,3R)-3-(5-FLUORO-4-PYRIMIDINYL)-2-(2,4-DIFLUOROPHENYL)-1-(1H-1,2,4-TRIA;UK109496;Vorionazole;2R,3S-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol;Vfend;Voriconazol;UK 109496;Voriconazolum;Voriconazole [USAN:INN:BAN];(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol;VCZ;JFU09I87TR;CPD000466350;C16H14F3N5O;(R-(R*,S*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineetha;NSC 759888;VORICONAZOLE [MART.];UNII-USG4B1CD29;(2R,3S)-2-(2,4-Difluoro-phenyl)-3-(5-fluoro-pyrimidin-4-yl)-1-[1,2,4]triazol-1-yl-butan-2-ol;HMS2051N09;VORICONAZOLE [USP-RS];DTXSID5046485;NC00191;VORICONAZOLE (USP-RS);BV164532;AB00639948-04;4-[[4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl]methylene]-1-oxo-1,3-thiazolidin-5-one;VORICONAZOLE [JAN];SW197571-2;A807215;Voriconazole, European Pharmacopoeia (EP) Reference Standard;Voriconazole in combination with MGCD290;2R,3S-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol-4-Pyrimidineethanol, ?-(2,4-difluorophenyl)-5-fluoro-?-methyl-?-(1H-1,2,4-triazol-1-ylmethyl)-,?(?R,?S)-;HY-76200;Voriconazole, (+/-)-;Z1521553720;VORICONAZOLE [USAN];MLS001424082;Voriconazole, Pharmaceutical Secondary Standard: Certified Reference Material;Vfend (TN);HMS3260M22;DTXCID3026485;(+/-)-Voriconazole;DTXSID201019420;VORICONAZOLE (USP MONOGRAPH);VORICONAZOLE [MI];(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl) butan-2-ol;CHEBI:10023;DRG-0301;VORICONAZOLE (MART.);(.ALPHA.R,.BETA.S)-A-(2,4-DIFLUOROPHENYL)-5-FLUORO-.BETA.-METHYL-.ALPHA.-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-4-PYRIMIDINEETHANOL;Q412236;HMS3713F12;DB00582;HY-W337569;Pharmakon1600-01502346;Voriconazole, VETRANAL(TM), analytical standard;137234-62-9;SMR000466350;NCGC00164622-04;VORICONAZOLE [EP MONOGRAPH];NS00007182;Voriconazole Vfend;Voriconazole, >=98% (HPLC);VORICONAZOLE (EP MONOGRAPH);AMY8903;4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-, (R-(R*,S*))-;BCPP000019;V0116;VORICONAZOLE [WHO-DD];4-PYRIMIDINEETHANOL, A-(2,4-DIFLUOROPHENYL)-5-FLUORO-.BETA.-METHYL-.ALPHA.-(1H-1,2,4-TRIAZOL-1-YLMETH...